5:32 PM
 | 
Dec 19, 2012
 |  BC Extra  |  Politics & Policy

States seek clarity on FDA authority over compounding

The majority of state representatives said on Wednesday that there is a role for federal regulation of certain types of higher risk non-traditional pharmacy compounding, but asked FDA to more clearly define what would require federal...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >